Polycystic Ovarian Syndrome Epidemiology

Key Highlights

• PCOS is a common hormonal disorder that often begins during adolescence, disrupting reproductive health by causing irregular menstrual cycles, elevated androgen levels, and the formation of ovarian cysts, with infertility being a common complication.
• Environmental pollutants, lifestyle choices, genetics, and gut microbiota imbalances, which together impact insulin resistance, hormonal levels, and inflammation, influence PCOS. Addressing these factors through lifestyle changes, detoxification, genetic insights, and gut health improvements is crucial for the effective management of the condition.
• The total diagnosed prevalent cases of PCOS in the 7MM are around 19,820,000 in 2024, and are expected to increase by 2034.
• The United States accounts for almost 50% of the total cases of PCOS in the 7MM.
• In the 7MM, females in the age group of 26-35 were the most affected by PCOS, with approximately 8,919,000 cases reported in 2024. This number is projected to increase by 2034.
• Among clinical manifestations of PCOS, polycystic ovaries were the most prevalent, with 2,465,000 cases reported in 2024 in Japan, followed by hyperandrogenemia. The numbers are expected to rise by 2034.
• Among EU4 and the UK, Germany accounted for the highest number of cases of PCOS in 2024, followed by the UK.

Report Summary

• The report offers extensive knowledge regarding the epidemiology segments and predictions, presenting a deep understanding of the potential future growth in diagnosis rates, disease progression, and diagnostic guidelines. It provides comprehensive insights into these aspects, enabling a thorough assessment of the subject matter.
• The report also encompasses a comprehensive analysis of PCOS, providing an in-depth examination of its historical and projected data from 2020 to 2034. It includes detailed assumptions and the underlying rationale for the methodology.

The table given below further depicts the key segments provided in the report:

Polycystic Ovarian Syndrome Disease Understanding

Polycystic Ovarian Syndrome Overview and Diagnosis

PCOS is the most common endocrine disorder in women, presenting with several possible combinations of signs and symptoms and a range of phenotypes, which may include reproductive, endocrine, and metabolic alterations. Polycystic ovary syndrome is characterized by hypothalamic-pituitary ovary axis dysfunction and anovulation but, unlike other causes of ovulatory failure that feature insufficient ovarian follicle growth or suppressed gonadotropin secretion (or both), polycystic ovary syndrome typically includes androgen excess and subtle alterations (not detected by routine tests) in serum levels of gonadotropins and estrogens. Doctors typically diagnose polycystic ovary syndrome in women who have at least two of these three symptoms: high androgen levels, irregular menstrual cycles, and cysts in the ovaries. Some of the symptoms of polycystic ovary syndrome are like those caused by other health problems because some tests are also considered, like Ultrasound and Blood tests.

Further details related to country-based variations are provided in the report…

Polycystic Ovarian Syndrome Epidemiology

The PCOS epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented as total diagnosed prevalent cases of PCOS, age-specific cases of PCOS, clinical manifestation-specific cases of PCOS and total treated cases of PCOS in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan from 2020 to 2034.

• PCOS is one of the most common causes of female infertility, affecting 6% to 13% of US women of reproductive age. 
• PCOS is thought to be very common, affecting about 1 in every 10 women in the UK.
• Up to 70% of affected women remain undiagnosed worldwide.
• In 2024, the total diagnosed prevalent cases of PCOS in the United States were found to be around 9,045,000, which, as per DelveInsight’s estimates, is expected to increase by 2034. Increased education and awareness campaigns have led more women to seek medical advice for PCOS symptoms.
• The age group of 26-35 years represented ~45% of PCOS cases in the United States, holding the leading position.
• PCOS manifests with various symptoms, including polycystic ovaries, hyperandrogenemia, amenorrhea, obesity, insulin resistance, hirsutism, acne, anxiety, and infertility. In 2024, approximately 55% of women in the US with PCOS experience infertility.

Polycystic Ovarian Syndrome Report Insights

• Patient Population
• PCOS Epidemiology Segmentation
• Existing Epidemiological Trends and Predictions

Polycystic Ovarian Syndrome Report Key Strengths

• Ten-year Forecast
• The 7MM Coverage
• PCOS Epidemiology Segmentation

Polycystic Ovarian Syndrome Report Assessment

• Epidemiological Trends and Disease Progression
• Qualitative Analysis (SWOT, Expert Insights, Unmet Needs)

Key Questions

• Would there be any changes observed in the epidemiological trends of PCOS?
• Will there be improvements in the understanding of PCOS progression?
• Would research advances lead to better epidemiological data for PCOS?
• How will the diagnostic testing space impact the epidemiology of PCOS?
• How will the prevalence and incidence of PCOS evolve in the coming years?

Reasons to buy

• Insights on disease burden, details regarding diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand the change in PCOS cases in varying geographies over the coming years.
• A detailed overview of total incident population, type-specific cases, gender-specific cases, stage-specific cases, and treatment-eligible incident population in early and advanced stages of PCOS is included.
• To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the treatment-eligible patient pool.
• Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.